- 全部删除
- 您的购物车当前为空
JSF-4898 是一种通过口服摄入起效的Mycobacterium tuberculosis MenG酶抑制剂,对Mycobacterium tuberculosis H37Rv的MIC为0.78 μM。JSF-4898 能够在小鼠中Mycobacterium tuberculosis亚急性感染模型中增强利福平的疗效。
JSF-4898 是一种通过口服摄入起效的Mycobacterium tuberculosis MenG酶抑制剂,对Mycobacterium tuberculosis H37Rv的MIC为0.78 μM。JSF-4898 能够在小鼠中Mycobacterium tuberculosis亚急性感染模型中增强利福平的疗效。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 待询 | |
50 mg | 待询 | 待询 |
JSF-4898 相关产品
产品描述 | JSF-4898 is an orally bioactive inhibitor of Mycobacterium tuberculosis MenG enzyme. It exhibits a minimum inhibitory concentration (MIC) of 0.78 μM against Mycobacterium tuberculosis H37Rv. Additionally, JSF-4898 enhances the efficacy of rifampicin in a subacute infection model of Mycobacterium tuberculosis in mice. |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容